Literature DB >> 32897221

Clinical comparative analysis of various duodenal diseases in different age groups.

Jin Zhao1, Xuelian Li1, Qi Liu1, Linyan Shi1, Ling Zhang1, Hong Yang1, Qianqian Zhang1.   

Abstract

BACKGROUND/AIMS: This study aimed to investigate the differences and relevance of various common duodenal diseases in different parts in the aspects of age, gender, helicobacter pylori (H. pylori) infection, application of nonsteroidal anti-inflammatory drugs (NSAIDs), smoking, or alcohol consumption.
MATERIALS AND METHODS: The medical records of various duodenal diseases were collected and tested for difference using the χ2 test or the Fisher exact probability method.
RESULTS: 1) The proportions of duodenal ulcer (DU), inflammation, and duodenal bulb diseases in the adult group (A) (47.98%, 36.70%, and 66.63%) were higher than those in the elderly group (E) (41.38%, 29.83%, and 56.82%), but the proportions of duodenal diverticulum (DD) and tumor diseases in the descending and ascending segments (2.95%, 1.43%, 9.14%, and 0.14%) were lower than those in group E (13.73%, 3.69%, 19.41%, and 0.76%) (p<0.001). 2) The positive rate of H. pylori (63.64%) in the duodenal bulb diseases was higher than that in the bulb-descending segment (53.75%), but the application rate of NSAIDs (16.44%) in the duodenal bulb-descending diseases was lower than that in the descending segment (24.81%) (p<0.001).
CONCLUSION: 1) DU, inflammation, and duodenal bulb diseases are common in adults, but DD and tumor diseases in the descending and ascending segments are more common in the elderly. 2) Compared with the duodenal bulb-descending diseases, the application of NSAIDs has greater impact on the diseases in the descending segment, and the rate of H. pylori infection is higher in duodenal bulb diseases.

Entities:  

Year:  2020        PMID: 32897221      PMCID: PMC7480196          DOI: 10.5152/tjg.2020.18712

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  33 in total

1.  [Prevalence reduction of duodenal ulcer: a Brazilian study. (retrospective analysis in the last decade: 1996-2005)].

Authors:  Carlos Saul; Cláudio Rolim Teixeira; Julio C Pereira-Lima; Ronaldo J Spinatto Torresini
Journal:  Arq Gastroenterol       Date:  2007 Oct-Dec

2.  Clinical outcome of endoscopic resection for nonampullary duodenal tumors.

Authors:  Satoru Nonaka; Ichiro Oda; Kazuhiro Tada; Genki Mori; Yoshinori Sato; Seiichiro Abe; Haruhisa Suzuki; Shigetaka Yoshinaga; Takeshi Nakajima; Takahisa Matsuda; Hirokazu Taniguchi; Yutaka Saito; Iruru Maetani
Journal:  Endoscopy       Date:  2014-10-14       Impact factor: 10.093

Review 3.  Challenges in the management of acute peptic ulcer bleeding.

Authors:  James Y W Lau; Alan Barkun; Dai-ming Fan; Ernst J Kuipers; Yun-sheng Yang; Francis K L Chan
Journal:  Lancet       Date:  2013-06-08       Impact factor: 79.321

Review 4.  Medicinal plant activity on Helicobacter pylori related diseases.

Authors:  Yuan-Chuen Wang
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.

Authors:  Francis K L Chan; Jessica Y L Ching; Yee Kit Tse; Kelvin Lam; Grace L H Wong; Siew C Ng; Vivian Lee; Kim W L Au; Pui Kuan Cheong; Bing Y Suen; Heyson Chan; Ka Man Kee; Angeline Lo; Vincent W S Wong; Justin C Y Wu; Moe H Kyaw
Journal:  Lancet       Date:  2017-04-11       Impact factor: 79.321

Review 6.  The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis.

Authors:  Alexander Sheh; James G Fox
Journal:  Gut Microbes       Date:  2013-08-19

Review 7.  Duodenal adenocarcinoma: Advances in diagnosis and surgical management.

Authors:  Jordan M Cloyd; Elizabeth George; Brendan C Visser
Journal:  World J Gastrointest Surg       Date:  2016-03-27

8.  [Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases].

Authors:  A A Samsonov; V B Grechushnikov; D N Andreev; G L Iurenev; T I Korovina; Iu A Lezhneva; I V Maev
Journal:  Ter Arkh       Date:  2014       Impact factor: 0.467

Review 9.  An overview of history, pathogenesis and treatment of perforated peptic ulcer disease with evaluation of prognostic scoring in adults.

Authors:  V Prabhu; A Shivani
Journal:  Ann Med Health Sci Res       Date:  2014-01

10.  Downward trend in the prevalence of Helicobacter pylori infections and corresponding frequent upper gastrointestinal diseases profile changes in Southeastern China between 2003 and 2012.

Authors:  Jian-Xia Jiang; Qing Liu; Xin-Yi Mao; Hai-Han Zhang; Guo-Xin Zhang; Shun-Fu Xu
Journal:  Springerplus       Date:  2016-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.